| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Fresenius Medical Care (NYSE:FMS) reported its Q4 earnings results on Tuesday, February 20, 2024 at 02:00 AM.
Here's what investors need to know about the announcement.
Fresenius Medical Care beat estimated earnings by 48.12%, reporting an EPS of $0.474 versus an estimate of $0.32.
Revenue was up $269.03 million from the same period last year.
Last quarter the company missed on EPS by $0.02 which was followed by a 3.29% increase in the share price the next day.
Here's a look at Fresenius Medical Care's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.33 | 0.24 | 0.13 | 0.24 |
| EPS Actual | 0.31 | 0.32 | 0.28 | 0.44 |
| Revenue Estimate | 5.28B | 5.19B | 5.33B | 5.20B |
| Revenue Actual | 5.37B | 5.26B | 5.05B | 5.10B |
To track all earnings releases for Fresenius Medical Care visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: FMS
